Skip to main content
. 2015 Apr 5;128(7):956–962. doi: 10.4103/0366-6999.154316

Figure 2.

Figure 2

Representative images of H and E stained (original magnification: [a-d] ×20 and [e-h] ×200) and toluidine blue stained (original magnification: ×200) bladders; (a, e, i) Control rats; (b, f, j) cyclophosphamide (CYP)-treated rats; (c, g, k) H-phloroglucinol-treated rats; (d, h, l) L-phloroglucinol-treated rats; (m) Inflammatory score; (n) Number of mast cells. Phloroglucinol treatment mitigated the severity of the rat of interstitial cystitis. CYP-treatment increases the number of mast cells, which was reversed by phloroglucinol treatment. Values are the mean ± standard error, n = 8. *P < 0.01 (vs. the control group); †P < 0.01 (vs. the CYP-treated group).